Xanthosine and xanthine: Substrate properties with purine nucleoside phosphorylases, and relevance to other enzyme systems

European Journal of Biochemistry

Volumn 269, Issue 16, 2002, Pages 4048-4057

  Stoychev, Gerasim ^a   Kierdaszuk, Borys ^a   Shugar, David ^a,b  

^a UNIVERSITY OF WARSAW   (Poland)

^b INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

Enzyme kinetics; Enzyme ligand interactions; pH dependence; Purine nucleoside phosphorylases; Xanthine xanthosine

Indexed keywords

6 THIOXANTHINE; ANION; ARSENIC ACID; CAFFEINE; GUANINE; GUANOSINE; HYPOXANTHINE; INOSINE; OXIDOREDUCTASE; PHOSPHORIBOSYLTRANSFERASE; PURINE NUCLEOSIDE PHOSPHORYLASE; RNA POLYMERASE; XANTHINE; XANTHOSINE;

ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; CATTLE; CELL PH; CHEMICAL STRUCTURE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DEPHOSPHORYLATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; EQUILIBRIUM CONSTANT; ERYTHROCYTE; HUMAN; HUMAN TISSUE; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ANIMALS; CATTLE; ENZYMES; ERYTHROCYTES; GUANINE; GUANOSINE; HUMANS; HYDROGEN-ION CONCENTRATION; HYPOXANTHINE; INOSINE; KINETICS; MODELS, CHEMICAL; MOLECULAR STRUCTURE; PROTEIN BINDING; PURINE-NUCLEOSIDE PHOSPHORYLASE; RIBONUCLEOSIDES; SPLEEN; STRUCTURE-ACTIVITY RELATIONSHIP; SUBSTRATE SPECIFICITY; XANTHINE; XANTHINES;

ANIMALIA; BOS TAURUS; MAMMALIA;

EID: 0036037393     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1033.2002.03097.x     Document Type: Article

References (63)

1. A second purine nucleoside phosphorylase in Escherichia coli K-12. I. Xanthosine phosphorylase regulatory mutants isolated as secondary-site revertants of a deoD mutant
2. A second purine nucleoside phosphorylase in Escherichia coli K-12. II. Properties of xanthosine phosphorylase and its induction by xanthosine
3. Purification and properties of inosine-guanosine phosphorylase from Escherichia coli K-12
4. Purine nucleoside phos-phorylase
5. Purine nucleoside phosphorylase: A target for chemotherapy
6. Purine nucleoside phosphorylases: Properties, functions, and clinical aspects
7. Enzymatic synthesis of desoxyxanthosine by the action xanthosine phosphorylase in mammalian tissue
8. Recycling of alpha-D-ribose 1-phosphate for nucleoside interconversion
9. Biosynthesis of the purines VI
10. Enzymes of the human erythrocytes. II. Purine nucleoside phosphorylase, specific properties
11. On the nature of xanthine and substituted xanthines in solution
12. Tautomerism and ionization of Xanthosine
13. Numerical data and functional relationships in science and technology
14. The crystal and molecular structure of the sodium salt of xanthine
15. Binding of phosphate and sulfate anions by purine nucleoside phosphorylase from E. coli: Ligand-dependent quenching of enzyme intrinsic fluorescence
16. Tautomeric forms and ionisation processes in xanthine and its N-methyl derivatives
17. NMR spectral characteristics of N-H protons in purine derivatives
18. Purine nucleoside phosphorylase. Allosteric regulation of a dissociating enzyme
19. Formycin A and its N-methyl analogues, specific inhibitors of E. coli purine nucleoside phosphorylase (PNP): Induced tautomeric shifts on binding to enzyme, and enzyme → ligand fluorescence resonance energy transfer
20. Purine nucleoside phosphorylase: Kinetics, mechanism, and specificity
21. Purine nucleoside phosphorylase. Catalytic mechanism and transition-state analysis of the arsenolysis reaction
22. Isolation of a hexameric form of purine nucleoside phosphorylase II from E. coli. Comparative study of trimeric and hexameric forms of the enzyme
23. Interaction of Escherichia coli purine nucleoside phosphorylase (PNP) with the cationic and zwitterionic forms of the fluorescent substrate N(7)-methylguanosine
24. Nicotinamide riboside, an unusual, non-typical, substrate of purified purine-nucleoside phosphorylases
25. Tautomerism of 6-thioxanthine in gas and aqueous phases using AM1 and PM3 methods
26. Tautomerism of 2-thioxanthine in the gas and aqueous phases using AM1 and PM3 methods
27. Metabolism of intravenously administered high-dose 6-mercaptopurine with and without allopurinol treatment in patients with non-Hodgkin lymphoma
28. Escherichia coli gpt gene sensitizes rat glioma cells to killing by 6-thioxanthine or 6-thioguanine
29. Regression of experimental brain tumors with 6-thioxanthine and Escherichia coli gpt gene therapy
30. Absorption, optical rotatory dispersion, and circular dichroism studies on some sulfur-containing ribonucleosides
31. Purine nucleoside phosphorylase. 3. Reversal of purine base specificity by site-directed mutagenesis
32. Inhibition of human purine nucleoside phosphorylase. Studies with intact erythrocytes and the purified enzyme
33. Calf spleen purine nucleoside phosphorylase complexed with substrates and substrate analogues
34. Transition state structure of purine nucleoside phosphorylase and principles of atomic motion in enzymatic catalysis
35. Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors
36. Crystal structure of calf spleen purine nucleoside phos-phorylase in a complex with hypoxanthine at 2.15 Å resolution
37. Crystal structure of the ternary complex of E. coli purine nucleoside phosphorylase with formycin B, a structural analogue of the substrate inosine, and phosphate (Sulphate) at 2.1 Å resolution
38. Purine nucleoside phosphorylase. 1. Structure-function studies
39. Purine nucleoside phosphorylase. 2. Catalytic mechanism
40. Structure-based drug design: Inhibitors of purine nucleoside phosphorylase
41. Structure-activity relationship for a class of inhibitors of purine nucleoside phosphorylase
42. Crystal structure of the purine nucleoside phosphorylase (PNP) from Cellulomonas sp. and its implication for the mechanism of trimeric PNPs
43. Structure-based design of inhibitors of purine nucleoside phos-phorylase. 1. 9-(arylmethyl) derivatives of 9-deazaguanine
44. Nucleoside and non-nucleoside IMP dehydrogenase inhibitors as antitumor and antiviral agents
45. Biochemical characterization of a novel hypoxanthine/xanthine dNTP pyrophosphatase from Methanococcus jannaschii
46. Biosynthesis and catabolism of caffeine in low-caffeine-containing species of Coffea
47. Structures of free and complexed forms of Escherichia coli xanthine-guanine phosphoribosyltransferase
48. Development of a bacterial screen for novel Hx-Gua PRTase substrates
49. Crystal structure of Escherichia coli xanthine phosphoribosyltransferase
50. Purine phosphoribosyl-transferases
51. Xanthine phosphoribosyltransferase from Leishmania donovani. Molecular cloning, biochemical characterization, and genetic analysis
52. The reductive half-reaction of xanthine oxidase. The involvement of prototropic equilibria in the course of the catalytic sequence
53. Effects of pH and temperature on the reaction of milk Xanthine oxidase with 1-methylxanthine
54. Recognition by viral and cellular DNA polymerases of nucleosides bearing bases with nonstandard hydrogen bonding patterns
55. Expanding the structural and functional diversity of RNA: Analog uridine triphosphates as candidates for in vitro selection of nucleic acids
56. Unnatural base pairs for specific transcription
57. Properties of poly-xanthylic acid and its reactions with potentially complementary homopolynucleotides
58. Polixanthylic acid: Structures of the ordered forms
59. Double-helical structures for polyxanthylic acid
60. Zur struktur des xanthins und seiner N-methyl-xanthin-derivate
61. Purine nucleoside phosphorylase: Inhibition by purine N(7)- and N(9)-acyclonucleosides; and substrate properties of 7-beta-D-ribofuranosylguanine and 7-beta-D-ribofuranosylhypoxanthine
62. Purine nucleoside phosphorylase. Kinetic mechanism of the enzyme from calf spleen
63. Fluorescence emission properties of 8-azapurines and their nucleosides, and application to the kinetics of the reverse synthetic reaction of purine nucleoside phosphorylase